Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.68 |
| ▸ | ATM | Q13315 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | PPARG | P37231 | 1/20 | 0.57 |
| ▸ | PPARD | Q03181 | 1/20 | 0.57 |
| ▸ | PPARA | Q07869 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.53 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.52 |
| ▸ | LDHA | P00338 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.51 |
| ▸ | CA9 | Q16790 | 2/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29559892 | 1.00 | CA2 (0.68) | CA2ATMKDM4EALDH1A1PPARG | |
| SCHEMBL9706259 | 0.86 | CA2 (0.52) | CA2ATMKDM4EPPARACYP1A2 | |
| SCHEMBL9705574 | 0.86 | CA2 (0.52) | CA2ATMKDM4EALDH1A1PPARG | |
| SCHEMBL9937910 | 0.84 | CA2 (0.48) | CA2ATMKDM4EALDH1A1PPARG | |
| SCHEMBL6794956 | 0.83 | CA2 (0.48) | CA2KDM4ESIGMAR1 | |
| SCHEMBL6358873 | 0.83 | CA2 (0.48) | CA2ATMKDM4EALDH1A1PPARG | |
| SCHEMBL6801155 | 0.83 | SIGMAR1 (0.51) | CA2SIGMAR1 | |
| SCHEMBL6353922 | 0.83 | CA2 (0.48) | CA2ATMKDM4EALDH1A1PPARG | |
| SCHEMBL516206 | 0.83 | ATM (0.66) | CA2ATMKDM4EALDH1A1PPARG | |
| SCHEMBL30764700 | 0.83 | ATM (0.66) | CA2ATMKDM4EALDH1A1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 365 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117843579-A | Benzo heterocycle coupled catechol derivative and preparation method and application thereof | 暨南大学 | 2024-04-09 | — | — | CN | claimed |
| CN-117025063-B | Preparation method of metal corrosion inhibition anticorrosive paint | 山东国智新材料科技有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-117025063-A | Preparation method of metal corrosion inhibition anticorrosive paint | 山东国智新材料科技有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-112538025-A | Preparation method of fluorine-containing compound for hydrophobic surface treatment agent | 湖北福力德鞋业有限责任公司 | 2021-03-23 | — | — | CN | claimed |
| US-20260131007-A1 | Mannose 6-Phosphate Receptor Binding Compounds for the Degradation of Extracellular Proteins | AVILAR THERAPEUTICS, INC. (US) | 2026-05-14 | — | — | US | disclosed |
| US-12534436-B2 | Disubstituted adamantyl derivative or pharmaceutically acceptable salt thereof, and pharmaceutical composition for suppressing cancer growth comprising same as active ingredient | ONECUREGEN CO., LTD. (KR) | 2026-01-27 | — | — | US | disclosed |
| EP-4638438-A1 | ALPHA4 BETA7 INTEGRIN ANTAGONISTS AND USES THEREOF | Xinthera, Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250214955-A1 | IMPROVED SYNTHETIC METHODS FOR MAKING LACTONES | P2 SCIENCE, INC. | 2025-07-03 | — | — | US | disclosed |
| CN-119977833-A | Synthesis and antitumor application of erianin derivative | 江苏海洋大学 | 2025-05-13 | — | — | CN | disclosed |
| CN-119859146-A | Gamma-lactam podophyllotoxin compound and preparation method and application thereof | 河南农业大学 | 2025-04-22 | — | — | CN | disclosed |
| CN-118388348-B | Steviol derivative and preparation method and application thereof | 广东工业大学 | 2024-12-27 | — | — | CN | disclosed |
| US-12162902-B2 | Decarboxylase inhibitors for treating Parkinson's disease | SAIL BIOMEDICINES (US) | 2024-12-10 | — | — | US | disclosed |
| EP-0031253-B1 | PROCESS FOR PREPARING 3,4-SUBSTITUTED BENZALDEHYDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-10-05 | — | — | EP | disclosed |
| EP-0073645-A2 | 2-Cyclic amino-2-(1,2-benzisoxazol-3-yl)acetic acid ester derivatives, process for the preparation thereof and composition containing the same | Dainippon Pharmaceutical Co., Ltd. (JP) | 1983-03-09 | — | — | EP | disclosed |
| US-4335263-A | MANY STEPS, STARTING WITH ACETYLATION OF M-CRESOL OR P-CRESOL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-06-15 | — | — | US | disclosed |
| EP-0034894-A2 | 2-(1-Piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives, processes for their preparation, intermediates used in the processes and the preparation thereof and pharmaceutical compositions containing the derivatives | AYERST, MCKENNA AND HARRISON INC. (CA) | 1981-09-02 | — | — | EP | disclosed |
| US-4280008-A | CHEMICAL INTERMEDIATES FOR OPTICALLY ACTIVE AMINO ACIDS | BASF AKTIENGESELLSCHAFT (DE) | 1981-07-21 | — | — | US | disclosed |
| EP-0031253-A1 | Process for preparing 3,4-substituted benzaldehydes | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-07-01 | — | — | EP | disclosed |
| US-4166062-A | HYPOTENSIVE AGENTS, CNS, ANTIDEPRESSANTS | THE UPJOHN COMPANY (US) | 1979-08-28 | — | — | US | disclosed |
| US-3962281-A | METHOD OF PREPARING ALDEHYDES | SAGAMI CHEMICAL RESEARCH CENTER (JA) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214955-A1 | IMPROVED SYNTHETIC METHODS FOR MAKING LACTONES | LSS, FDPS, NISCH | CA2 3677/4885ATM 3914/4885KDM4E 2200/4885 |
| US-20260131007-A1 | Mannose 6-Phosphate Receptor Binding Compounds for the Degradation of Extracellular Proteins | IGF2R, M6PR, MSR1 | CA2 2683/4885ATM 3428/4885KDM4E 3769/4885 |
| US-12162902-B2 | Decarboxylase inhibitors for treating Parkinson's disease | DDC, DDT, DDO | CA2 2384/4885ATM 2487/4885KDM4E 2529/4885 |
| US-12534436-B2 | Disubstituted adamantyl derivative or pharmaceutically acceptable salt thereof, and pharmaceutical composition for suppressing cancer growth comprising same as active ingredient | CS, AK2, TFAM | CA2 435/4885ATM 1591/4885KDM4E 1847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.